Helicobacter pylori vacA s1m1/cagA+ promotes increased expression of IFN-γ and IL-17A in human mononuclear cells
The persistent infection of the gastric mucosa by Helicobacter pylori (H. pylori) and the resulting chronic inflammation are a risk factor for gastric carcinogenesis.
Helicobacter pylori and Helicobacter cinaedi infection in patients with cardiovascular disease
Cardiovascular diseases (CVD) are the leading cause of morbidity and mortality worldwide. It is estimated that 75% of deaths occur in developing countries.
Epithelial barrier disruption and gastric cancer signaling by Helicobacter Pylori
The Helicobacter pylori type IV secretion system (T4SS) encoded by the cag pathogenicity island forms needle-like pili, whose binding to the integrin-β1 receptor results in injection of the CagA oncoprotein.
Prevalence of Cytotoxin-associated gene A-positive Helicobacter pylori strains in two areas with different burden of gastric cancer in Chile
Helicobacter pylori is the most important pathogen associated with gastric diseases, including gastric cancer. Cytotoxin-associated gene A (CagA) is an oncoprotein and a major virulence factor of H. pylori.
Antimicrobial activity against Helicobacter pylori of nine strains of Lactobacillus plantarum isolated from goat cheese produced in the region of Coquimbo, north of Chile
Helicobacter pylori is an infectious agent associated with gastrointestinal diseases. There are several reports about the use of probiotics strains with antimicrobial activity, as treatment to eradicate H. pylori.
Evaluation of the Use of Vitamin C and E supplements concomitantly to antibiotic treatment against Helicobacter Pylori: A systematic review and meta analysis
The Helicobacter pylori infection is the main cause of diseases benign and maligns gastrointestinal. Although, the cure clinical rate has reduced for an increase of antimicrobial resistance in worldwide. For this reason, the search of alternatives that might optimize the effectiveness is a need.